Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.79
(-1.56%)
CNY 3.79
(-1.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.34 Billion CNY | -248.92% |
| 2022 | 500.42 Million CNY | 480.2% |
| 2021 | -269.95 Million CNY | -90.09% |
| 2020 | 1.47 Billion CNY | 331.03% |
| 2019 | 323.93 Million CNY | 60.26% |
| 2018 | 193.46 Million CNY | -14.36% |
| 2017 | 249.16 Million CNY | 35.8% |
| 2016 | 161.57 Million CNY | 73.77% |
| 2015 | 84.78 Million CNY | 46.43% |
| 2014 | 62.91 Million CNY | 52.7% |
| 2013 | 50.29 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -326.81 Million CNY | 91.19% |
| 2024 Q3 | -143.02 Million CNY | -282.56% |
| 2024 Q2 | -169.68 Million CNY | 162.03% |
| 2023 Q4 | -1.43 Billion CNY | -239.84% |
| 2023 FY | - CNY | -248.92% |
| 2023 Q1 | -114.16 Million CNY | -544.97% |
| 2023 Q2 | -539.61 Million CNY | -372.66% |
| 2023 Q3 | -421.9 Million CNY | 21.81% |
| 2022 Q1 | -351.59 Million CNY | 58.01% |
| 2022 FY | - CNY | 480.2% |
| 2022 Q3 | 279.94 Million CNY | 194.16% |
| 2022 Q4 | -17.7 Million CNY | -106.32% |
| 2022 Q2 | -297.31 Million CNY | 15.44% |
| 2021 Q3 | -327.53 Million CNY | -177.5% |
| 2021 Q4 | -837.27 Million CNY | -155.63% |
| 2021 Q1 | 396 Million CNY | 46.5% |
| 2021 Q2 | -118.03 Million CNY | -129.81% |
| 2021 FY | - CNY | -90.09% |
| 2020 Q4 | 270.3 Million CNY | -18.43% |
| 2020 Q2 | 349.47 Million CNY | 20.98% |
| 2020 FY | - CNY | 331.03% |
| 2020 Q1 | 288.87 Million CNY | 535.05% |
| 2020 Q3 | 331.38 Million CNY | -5.18% |
| 2019 FY | - CNY | 60.26% |
| 2019 Q4 | 45.48 Million CNY | -34.36% |
| 2019 Q3 | 69.29 Million CNY | 84.78% |
| 2019 Q2 | 37.5 Million CNY | -33.57% |
| 2019 Q1 | 56.45 Million CNY | 71.49% |
| 2018 Q2 | -4.26 Million CNY | -108.35% |
| 2018 Q4 | 32.92 Million CNY | -13.87% |
| 2018 Q3 | 38.22 Million CNY | 996.31% |
| 2018 FY | - CNY | -14.36% |
| 2018 Q1 | 51.08 Million CNY | 175.46% |
| 2017 FY | - CNY | 35.8% |
| 2017 Q1 | 61.37 Million CNY | 220.78% |
| 2017 Q2 | 46.65 Million CNY | -23.99% |
| 2017 Q3 | 57.17 Million CNY | 22.55% |
| 2017 Q4 | 18.54 Million CNY | -67.56% |
| 2016 Q4 | 19.13 Million CNY | -41.54% |
| 2016 FY | - CNY | 73.77% |
| 2016 Q3 | 32.72 Million CNY | 0.0% |
| 2015 FY | - CNY | 46.43% |
| 2014 FY | - CNY | 52.7% |
| 2013 FY | - CNY | 0.0% |